Abstract: A method for making a surface modified biomedical device is disclosed, the method comprising contacting a surface of a biomedical device with a copolymer which is the reaction product of one or more polymerizable polyhydric alcohols and one or more polymerizable fluorine-containing monomers.

Abstract: A process for treating a medical device involves: (a) treating a silicon-containing biomedical device with an organic solvent that swells the device, and treating the device with a hydrophilic, monomeric material; and (b) exposing the biomedical device and the hydrophilic, monomeric material to heat or light radiation to polymerize the hydrophilic, monomeric material.

Abstract: A process for treating a silicone hydrogel biomedical device, especially an ophthalmic lens such as a contact lens, involves: immersing the silicone hydrogel biomedical device with a mixture of an organic solvent and a hydrophilic, polymeric material, for a sufficient time that the device is swollen in volume by at least 30%; and removing the organic solvent from the device while retaining at least a portion of the hydrophilic polymeric material therein.

Abstract: A method of preparing a biomedical device is disclosed. The method involves the steps: (a) cast molding at least one biomedical device formed from a monomer mixture comprising at least one silicone-containing monomer and at least one hydrophilic monomer in a mold assembly, the mold assembly comprising at least one anterior mold part made of a first plastic material and one posterior mold part made of a second plastic material, wherein the first plastic material is more polar relative to the second plastic material; and (b) contacting a surface of the biomedical device with a solution comprising a proton-donating wetting agent, whereby the wetting agent forms a complex with the hydrophilic monomer on the surface of the biomedical device.

Abstract: Disclosed are methods for making a surface modified biomedical device involving (a) exposing a biomedical device having a plurality of biomedical device surface functional groups to one or more ethylenically unsaturated-containing organic compounds having a reactive group that is co-reactive to the biomedical device surface functional groups of the biomedical device; and (b) graft polymerizing a hydrophilic reactive monomer having a complementary reactive functionality with the ethylenically unsaturated functionalities of the ethylenically unsaturated-containing organic compounds on or near the surface of the biomedical device thus forming a biocompatible surface on the biomedical device. The methods disclosed are two-step methods and do not include any additional surface treatment steps.

Abstract: A silicone hydrogel comprising monomeric units of one or more amino monomers, wherein the amino monomers are of formula IA, IB, IIA or IIB and monomeric units of one or more silicone monomers wherein R1, R2 and R3 are independently selected from hydrogen, C1-C6 alkyl or CH2OH; R4 is a C1-C10 alkyl optionally substituted with hydroxyl or carboxylic acid; E is a polymerizable group; X is an anion suitable for quaternary nitrogen; and n is 0, 1, 2, or 3 and m is an integer from 1 to 8.

Abstract: Provided are surface modified contact lenses formed from one or more fumaric- or itaconic-containing prepolymers having reactive functionality that is complimentary to surface modifying polymers.

Abstract: Provided are surface modified contact lenses formed from one or more fumaric- or itaconic-containing prepolymers having polymerizable functionality that is complimentary to polymerizable hydrophilic polymers.

Abstract: Disclosed are ophthalmic solutions such as packaging solutions for storing ophthalmic devices and lens care solutions for cleaning, disinfecting, rinsing and/or storing ophthalmic devices. The ophthalmic solutions contain at least a polymerization product obtained from a monomeric mixture comprising (a) a monomer bearing a center of permanent positive charge and (b) a non-ionic ethylenically unsaturated monomer, wherein the solution has an osmolality of at least about 200 mOsm/kg, and a pH of about 4 to about 9.

Abstract: Prepolymers comprising at least one block of Formula II and terminated with a polymerizable ethylenically unsaturated radical are useful in hydrogel materials are disclosed: wherein n, R, R1, R2 and X+ are as defined herein.

Abstract: A polysiloxane copolymer that is useful for forming biomedical devices comprises blocks (I) and (II) and is terminated at each end with an ethylenically unsaturated radical: (*Dii*Diol*Dii*PS)x ??(I) (*Dii*PS)y ??(II) wherein: each Dii is independently a diradical residue of a diisocyanate; each Diol is independently a diradical residue of a diol having 1 to 10 carbon atoms; each PS is independently a diradical residue of a polysiloxane-containing diol or diamine; each * is independently —NH—CO—NH—, —NH—COO— or —OCO—NH—: x represents the number of blocks (I) and is at least 2, and y represents the number of blocks (II) and is at least 1.

Abstract: An ophthalmic composition comprising a copolymer and one or more cationic antimicrobial components. The copolymer comprises monomeric units of one or more polymerizable alcohols or polymerizable polyols, and monomeric units of one or more polymerizable carboxylic acids. Also, the composition has an osmolality from 200 mOsmol/kg to 400 mOsmol/kg.

Abstract: The present invention is directed to new and improved packaging systems for storing ophthalmic devices such as contact lenses and to methods for packaging such ophthalmic devices with solutions to improve the comfort of the lenses during wear. In particular, the present invention is directed to a packaging system for storing an ophthalmic device in an aqueous packaging solution comprising hyaluronic acid or a salt thereof. Such solutions are retained on the surface of an unused lens for extended periods of time, resulting in surface modification that persists in the eye, which may provide significant improvement in the wetting properties of fresh contact lenses used for the first time and, moreover, even several hours after lens insertion, thereby preventing dryness and improving lubricity.

Abstract: A macromonomer comprises an ?,?-conjugated terminal carboxylic group and a plurality of hydrophilic groups. Polymeric materials comprise such a macromonomer are used advantageously to provide a hydrophilic or lubricious (or both) coating on medical devices. Such polymeric materials can comprise units of other hydrophilic monomers.

Abstract: A macromonomer of the present invention comprises at least functional group and a plurality of hydrophilic moieties. Such a functional group can be an ethylenically unsaturated group that comprises acrylate, methacrylate, sinapate (or 3,5-dimethoxy-4-hydroxycinnamate), cinnamate (or 3-phenylacrylate), senecioate (or 3,3-dimethylacrylate), crotonate, maleate, fumarate, itaconate, vinyl, allyl, or styryl group. Polymeric materials comprise such a macromonomer are used advantageously to provide a hydrophilic or lubricious (or both) coating on polymeric articles, such as medical devices. Such polymeric materials can comprise units of other hydrophilic monomers.

Abstract: A medical device having an increased surface hydrophilicity comprises a coating polymer comprising units of a polymerizable hydrophilic compound that is attached to the surface of the medical device via the Michael addition reaction. The coating polymer can be applied to a medical device comprising a hydrogel material. The attachment of the coating polymer may be enhanced by increasing the population of the medical-device surface functional groups before contacting the medical device with the coating polymer.

Abstract: A copolymer comprising monomeric units of one or more polymerizable polyalcohols selected from the groups consisting of erythritol, xylitol, sorbitol and mixtures thereof; and one or more polymerizable carboxylic acids.

Abstract: A medical device having an increased surface hydrophilicity comprises a coating polymer comprising units of a polymerizable hydrophilic compound, such as a polymerizable polyhydric alcohol. The coating polymer can be applied to a medical device comprising a hydrogel material. The medical device can have a reduced dehydration rate compared to a device that is devoid of such a coating polymer and/or provide increased comfort to a user.

Abstract: A method of making a silicone hydrogel biomedical device involves forming a monomer mixture comprising a silicone-containing monomer and a hydrophilic monomer, and heating the monomer mixture to reduce cloudiness of the mixture.

Abstract: Hydrogel copolymers are useful for forming biomedical devices, particularly ophthalmic devices including contact lenses, intraocular lenses and ophthalmic implants. The copolymers have a desirable combination of oxygen permeability, tensile modulus, and water content, especially for soft contact lenses.